FDA approves first blood test to support Alzheimer’s diagnosis The Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio enables early detection of amyloid plaques through a non-invasive blood test
Roche Diagnostics launches India’s first automated cerebrospinal fluid (CSF)-based test for… Current diagnosis of Alzheimer’s Disease (AD) is often done through clinical assessment and routine imaging tests which may not…
